ENTITY

Vcanbio Cell & Gene Engineering (600645 CH)

27
Analysis
Health Care • China
Vcanbio Cell & Gene Engineering Corp., Ltd provides health care testing services. The Company offers stem cell inspection, detection reagent, gene inspection, and other other services. Vcanbio Cell & Gene Engineering also provides pharmaceutical intermediates research, experimental comprehensive agents development, and other services.
more
bullish•Cordlife
•02 Jul 2016 10:49

Nanjing Xinjiekou Takes Cordlife Stake

Nanjing Xinjiekou Department Store Co., Ltd. has announced agreements to buy 20% of SGX-listed Cordlife Group from current shareholders Wells...

Share
bullish•Global Cord Blood
•27 Oct 2015 11:03

QUICKNOTE: Golden Meditech and Nanjing Xinjiekou Team Up

The China Cord Blood bidding process continues to evolve in unexpected ways with Golden Meditech announcing an MOU with Nanjing Xinjiekou. We...

Share
bullish•Global Cord Blood
•17 Sep 2015 05:00

QUICKNOTE: Cordlife Holders Vote in Favor of Golden Meditech Deal

Cordlife Group's (CLGL:SP) shareholders voted overwhelmingly in favor of selling the company's holdings of China Cord Blood (CO:US) to Golden...

Share
bullish•Global Cord Blood
•10 Sep 2015 04:01

Update: Zhongyuan Drops Out of the Bidding

Zhongyuan Union & Cell Engineering Corp (600645: Shanghai) has dropped out of the bidding process for China Cord Blood (CO:US), citing the...

Share
bullish•Global Cord Blood
•28 Aug 2015 05:02

Update: Mr. Kam Raises His Stake, and Nanjing Xinjiekou Ups the Pressure

The bidding war for China Cord Blood has heated up. China Cord Blood's Chairman has acquired KKR's 19% stake through a restructured purchase...

Share
x